UTRS vs. AFIB, STSS, VERO, GMVDF, IONM, TMDIF, AVGR, AEMD, NURO, and TNON
Should you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Acutus Medical (AFIB), Sharps Technology (STSS), Venus Concept (VERO), G Medical Innovations (GMVDF), Assure (IONM), Titan Medical (TMDIF), Avinger (AVGR), Aethlon Medical (AEMD), NeuroMetrix (NURO), and Tenon Medical (TNON). These companies are all part of the "surgical & medical instruments" industry.
Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation.
Acutus Medical received 5 more outperform votes than Minerva Surgical when rated by MarketBeat users. However, 41.18% of users gave Minerva Surgical an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote.
Minerva Surgical has a net margin of -64.71% compared to Minerva Surgical's net margin of -166.79%. Minerva Surgical's return on equity of -35.31% beat Acutus Medical's return on equity.
Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.
Acutus Medical has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Minerva Surgical has a consensus price target of $20.00, suggesting a potential upside of 4,778.05%. Given Acutus Medical's higher probable upside, analysts clearly believe Minerva Surgical is more favorable than Acutus Medical.
56.9% of Acutus Medical shares are held by institutional investors. 3.5% of Acutus Medical shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Acutus Medical had 5 more articles in the media than Minerva Surgical. MarketBeat recorded 6 mentions for Acutus Medical and 1 mentions for Minerva Surgical. Acutus Medical's average media sentiment score of 0.00 beat Minerva Surgical's score of -0.07 indicating that Minerva Surgical is being referred to more favorably in the news media.
Summary
Minerva Surgical beats Acutus Medical on 9 of the 16 factors compared between the two stocks.
Get Minerva Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Minerva Surgical Competitors List
Related Companies and Tools
